Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SØNDERJYSK DNA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   4.9% 3.8% 3.0% 2.0% 1.8% 2.6% 16.4% 16.1%   Credit score (0-100)   45 51 56 68 70 62 11 11   Credit rating   BBB BBB BBB A A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   678 677 1,063 1,041 863 825 0.0 0.0   EBITDA   106 125 556 334 238 115 0.0 0.0   EBIT   101 124 540 319 223 99.9 0.0 0.0   Pre-tax profit (PTP)   92.0 121.1 538.5 321.7 205.9 83.1 0.0 0.0   Net earnings   88.8 92.5 420.0 249.7 159.6 64.8 0.0 0.0   Pre-tax profit without non-rec. items   92.0 121 538 322 206 83.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 76.3 60.7 45.2 29.7 14.1 0.0 0.0   Shareholders equity total   172 205 545 594 554 419 179 179   Interest-bearing liabilities   0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   725 898 1,274 1,382 1,078 914 179 179   Net Debt   -45.3 -124 -215 -43.2 -48.9 -11.5 -179 -179     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   678 677 1,063 1,041 863 825 0.0 0.0   Gross profit growth   23.9% -0.2% 57.2% -2.1% -17.1% -4.4% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   725 898 1,274 1,382 1,078 914 179 179   Balance sheet change%   -7.4% 23.9% 41.9% 8.4% -22.0% -15.2% -80.4% 0.0%   Added value   106.1 125.0 555.8 334.2 238.2 115.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -10 75 -31 -31 -31 -31 -14 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.9% 18.3% 50.8% 30.6% 25.8% 12.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.5% 15.2% 49.7% 24.8% 18.1% 10.0% 0.0% 0.0%   ROI %   79.5% 65.6% 136.9% 55.7% 38.6% 20.2% 0.0% 0.0%   ROE %   69.4% 49.1% 112.1% 43.8% 27.8% 13.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   23.8% 22.8% 42.7% 43.0% 51.4% 45.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -42.7% -99.2% -38.8% -12.9% -20.5% -10.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 6.8% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 9.8% 41.6% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.3 0.2 0.6 0.3 0.2 0.2 0.0 0.0   Current Ratio   1.2 1.1 2.0 1.8 2.0 1.8 0.0 0.0   Cash and cash equivalent   45.3 124.0 252.4 43.2 48.9 11.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   123.3 66.4 575.2 561.3 501.8 378.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   53 63 278 167 119 58 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   53 63 278 167 119 58 0 0   EBIT / employee   51 62 270 159 111 50 0 0   Net earnings / employee   44 46 210 125 80 32 0 0